Beryl Rica Benacerraf
Renowned radiologist and pioneer of ultrasound in antenatal diagnosis. She was born in New York, NY, USA, on April 29, 1949 and died of cancer in Cambridge, MA, USA, on Oct 1, 2022 aged 73 years.
Related Articles
New studies suggest GLP-1 health care costs have only begun to climb
Costs for the U.S. health care system and the federal government will climb thanks to weight loss drugs, two new reports show.
Refining the impact of genetic evidence on clinical success
Nature – Human genetic evidence increases the success rate of drugs from clinical development to approval but we are still far from reaching peak genetic…
Refining the impact of genetic evidence on clinical success
Nature – Human genetic evidence increases the success rate of drugs from clinical development to approval but we are still far from reaching peak genetic…
Refining the impact of genetic evidence on clinical success
Nature – Human genetic evidence increases the success rate of drugs from clinical development to approval but we are still far from reaching peak genetic…
Structure peer review to make it more robust
Nature – Everyone who reviews a manuscript should answer a transparent set of questions, to ensure that scientific literature is subject to reliable quality control.
Graduate Medical Education Resources: HR Information | Mass General Brigham
Learn about how human resources information and trainings offered through the graduate medical education programs help facilitate a world-class experience.
Structure peer review to make it more robust
Nature – Everyone who reviews a manuscript should answer a transparent set of questions, to ensure that scientific literature is subject to reliable quality control.
SGLT2i vs Sulfonylureas for Gout Prevention Among Patients With Type 2 Diabetes Receiving Metformin
This cohort study uses target trial emulation to evaluate risk of incident gout and rate of recurrent gout flares in patients with type 2 diabetes…
Burden of Mendelian disorders in a large Middle Eastern biobank – Genome Medicine
Background Genome sequencing of large biobanks from under-represented ancestries provides a valuable resource for the interrogation of Mendelian disease burden at world population level, complementing…
Vertex to buy Alpine Immune Sciences for $4.9 billion
Vertex Pharmaceuticals will buy Alpine Immune Sciences, a maker of protein-based medicines that harness the immune system, for $4.9 billion.